In addition, elevated levels of MCP-1 in AD patients have also been found in other studies and the previous meta-analysis, which are consistent with our outcomes (Galimberti et al., 2006; Lee et al., 2018; Shen et al., 2019). This evidence concerns the gene CCL2 and Alzheimer disease.